 |
BioWorld-Insight-2003-05-26
Money Raised Year To Date
Biotech - Big Pharma Collaborations: Modified And Terminated Agreements, March 25 - May 21, 2003#
No Abstract
Happier ASCO News Due As Avastin Data Take Center Stage
Among the headliners at the upcoming meeting of the American Society of Clinical Oncology are details on the eye-opening success of Genentech Inc.'s vascular endothelial growth factor drug Avastin (bevacizumab) in Phase III trials for metastatic colorectal cancer and long-awaited word regarding scandal-plagued ImClone System Inc.'s cancer drug Erbitux.
But that's hardly all.